Cetyl palmitate; Hexadecyl palmitate; 540-10-3; Palmityl palmitate; Hexadecyl hexadecanoate; Cetin; Hexadecanoic acid, hexadecyl ester; Hexadecanoic acid hexadecyl ester; Standamul 1616; hexadecanyl hexadecanoate; n-Hexadecyl hexadecanoate; Palmitic acid palmityl ester; UNII-5ZA2S6B08X; MFCD00053739; PALMITIC ACID, HEXADECYL ESTER; Cetyl palmitate [NF]; palmitic acid, cetyl ester; 5ZA2S6B08X; CHEBI:75584; WE(16:0/16:0); Cetyl palmitate (NF); n-Hexadecyl palmitate, 95%; n-Hexadecyl palmitate, 98%; 95912-87-1; Palmitic Acid Hexadecyl Ester; n-hexadecyl palmitate; EINECS 208-736-6; BRN 1805188; Schercemol CP; Crodamol CP; Precifac ATO; Rewowax CG; Starfol CP; Cutina CP; Palmitic acid cetyl; EINECS 309-375-8; Waxenol 815; Kessco 653; n-hexadecanyl palmitate; Radia 7500; 1-Hexadecyl hexadecanoate; ACMC-209lc5; SCHEMBL44487; Palmityl palmitate, >=99%; Palmatic acid n-hexadecyl ester; CHEMBL2106073; DTXSID5047114; ZINC8437455; Hexadecyl ester of hexadecanoic acid; ANW-31923; LMFA07010001; SBB058698; AKOS015903369; CS-W011523; MCULE-7099724921; 100231-74-1; AK307392; DS-11394; DB-052456; FT-0632345; P1077; ST51037392; 2801-EP2305668A1; C13821; D08888; Fatty acids, C16-18, C12-18-alkyl esters; Q409361; UNII-58B69Q84JO component PXDJXZJSCPSGGI-UHFFFAOYSA-N; UNII-8Z79DN5I1B component PXDJXZJSCPSGGI-UHFFFAOYSA-N; UNII-D072FFP9GU component PXDJXZJSCPSGGI-UHFFFAOYSA-N; UNII-MVY7P518D2 component PXDJXZJSCPSGGI-UHFFFAOYSA-N; UNII-QV6353F6TG component PXDJXZJSCPSGGI-UHFFFAOYSA-N; UNII-UVI52NPK6G component PXDJXZJSCPSGGI-UHFFFAOYSA-N; Cetyl palmitate 15, European Pharmacopoeia (EP) Reference Standard; Cetyl palmitate 95, European Pharmacopoeia (EP) Reference Standard; Cetyl palmitate, United States Pharmacopeia (USP) Reference Standard; Cetyl Palmitate, Pharmaceutical Secondary Standard; Certified Reference Material